121 related articles for article (PubMed ID: 32736684)
1. 5-Aza-2-deoxycytidine inhibits osteolysis induced by titanium particles by regulating RANKL/OPG ratio.
Wang Y; Liu H; Wu J; Liao Y; Lu D; Dong F; Li H; Zhang Z; Lian Y
Biochem Biophys Res Commun; 2020 Aug; 529(3):629-634. PubMed ID: 32736684
[TBL] [Abstract][Full Text] [Related]
2. Cepharanthine ameliorates titanium particle-induced osteolysis by inhibiting osteoclastogenesis and modulating OPG/RANKL ratio in a murine model.
Liao L; Lin Y; Liu Q; Zhang Z; Hong Y; Ni J; Yu S; Zhong Y
Biochem Biophys Res Commun; 2019 Sep; 517(3):407-412. PubMed ID: 31376931
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate reduces the progression of titanium particle-induced osteolysis by increasing the ratio of osteoprotegerin to receptor activator of nuclear factor-κB ligand in vivo.
Geng T; Sun S; Chen X; Wang B; Guo H; Zhang S; Jin Q
Mol Med Rep; 2018 Mar; 17(3):3829-3836. PubMed ID: 29257329
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo.
Liu X; Zhu S; Cui J; Shao H; Zhang W; Yang H; Xu Y; Geng D; Yu L
Acta Biomater; 2014 Nov; 10(11):4912-4918. PubMed ID: 25078426
[TBL] [Abstract][Full Text] [Related]
5. MiR-377 inhibits wear particle-induced osteolysis via targeting RANKL.
Li W; Wang X; Chang L; Wang F
Cell Biol Int; 2019 Jun; 43(6):658-668. PubMed ID: 30958621
[TBL] [Abstract][Full Text] [Related]
6. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
Niu J; Bi F; Tian Q; Tian K
J Arthroplasty; 2024 Jul; 39(7):1845-1855. PubMed ID: 38336308
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen deficiency modulates particle-induced osteolysis.
Nich C; Langlois J; Marchadier A; Vidal C; Cohen-Solal M; Petite H; Hamadouche M
Arthritis Res Ther; 2011 Jun; 13(3):R100. PubMed ID: 21696618
[TBL] [Abstract][Full Text] [Related]
8. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
9. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.
Yang C; Liu W; Zhang X; Zeng B; Qian Y
J Orthop Surg Res; 2020 Dec; 15(1):600. PubMed ID: 33302980
[TBL] [Abstract][Full Text] [Related]
10. Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis.
Wang P; Cao Y; Zhan D; Wang D; Wang B; Liu Y; Li G; He W; Wang H; Xu L
Int J Med Sci; 2018; 15(13):1480-1485. PubMed ID: 30443169
[No Abstract] [Full Text] [Related]
11. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
Ihn HJ; Kim K; Cho HS; Park EK
Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of COX-2 inhibitor on titanium-particle-induced inflammatory osteolysis via the down-regulation of RANK/RANKL.
Geng D; Mao H; Wang J; Zhu X; Huang C; Chen L; Yang H; Xu Y
Acta Biomater; 2011 Aug; 7(8):3216-21. PubMed ID: 21601661
[TBL] [Abstract][Full Text] [Related]
14. Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles.
Masui T; Sakano S; Hasegawa Y; Warashina H; Ishiguro N
Biomaterials; 2005 May; 26(14):1695-702. PubMed ID: 15576143
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
[TBL] [Abstract][Full Text] [Related]
16. Rifampin suppresses osteoclastogenesis and titanium particle-induced osteolysis via modulating RANKL signaling pathways.
Zhu L; Kang H; Guo CA; Fan WS; Wang YM; Deng LF; Yan ZQ
Biochem Biophys Res Commun; 2017 Feb; 484(1):64-70. PubMed ID: 28108285
[TBL] [Abstract][Full Text] [Related]
17. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure.
Zhang T; Yu H; Gong W; Zhang L; Jia T; Wooley PH; Yang SY
Biomaterials; 2009 Oct; 30(30):6102-8. PubMed ID: 19665222
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of p38 MAPK inhibitor on wear debris-induced inflammatory osteolysis through downregulating RANK/RANKL in a mouse model.
Chen D; Li Y; Guo F; Lu Z; Hei C; Li P; Jin Q
Genet Mol Res; 2015 Jan; 14(1):40-52. PubMed ID: 25729934
[TBL] [Abstract][Full Text] [Related]
19. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
[TBL] [Abstract][Full Text] [Related]
20. [The participation of RANK, RANKL and OPG in tumor osteolysis].
Stanisławowski M; Kmieć Z
Postepy Hig Med Dosw (Online); 2009 May; 63():234-41. PubMed ID: 19502684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
